Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Short-Term Debt repayments (2023 - 2025)

bioAffinity Technologies (BIAF) has disclosed Short-Term Debt repayments for 2 consecutive years, with -$101156.0 as the latest value for Q3 2025.

  • Quarterly Short-Term Debt repayments changed N/A to -$101156.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $11795.0 through Sep 2025, changed N/A year-over-year, with the annual reading at $251746.0 for FY2023, N/A changed from the prior year.
  • Short-Term Debt repayments for Q3 2025 was -$101156.0 at bioAffinity Technologies, down from $74024.0 in the prior quarter.
  • The five-year high for Short-Term Debt repayments was $126096.0 in Q2 2023, with the low at -$101156.0 in Q3 2025.